Overview

Leadless Pacemakers Market Overview: Leadless pacemakers market is forecasted to value over US$ 260 million by the end of 2027 and growing at a CAGR of over 21% during the forecast period, 2020 to 2027. Leadless pacemakers are medical devices which are used for the treatment of patients suffering from cardiac problems such as arrhythmias. These are complete enclosed capsules which include pacemakers and electronic source. Further, leadless pacemakers are implantable devices transplanted directly in the right ventricle of the heart where it sends small electrical impulses to the heart muscles to continue at an acceptable heart rate. Additionally, leadless pacemakers are less invasive as compared to traditional pacemakers and can be implanted within an hour. Leadless pacemakers take less time to recover and also eliminate problems related to trans-venous leads such as lead fracture, insulation breaks and other. Leadless pacemakers produce comparatively less radiation and have better life quality without causing any infection to the heart ventricle. According to World Society of Arrhythmia, over one million of cardiac pacemakers are implanted every year. Market is majorly driven by rising geriatric population and increasing prevalence of heart diseases. Along with this, technological evolution led to rapid advancement of pacemakers. It improved the safety & efficacy of the pacemakers and improved the management of arrhythmias. Leadless pacing reduces complication of transvenous pacemaker procedure and increased the success rate disease management. Further, increasing importance of leadless pacemakers over traditional methods led to potential growth of the market. Further, increasing government support and changing demographics of general population fuelled the growth of the market. Global market is dominated by North America due to high adoption of leadless pacemakers. In North America, US dominated the market and it accounts more 90% of the market share during forecast period. Europe market is majorly dominated by UK, Germany and France due to high penetration among the end user segment. Asia Pacific is expected to create new opportunities for manufacturers due to increasing adoption. It is majorly dominated by Japan, China & India and it is expected to register highest growth rate. It is followed by Latin America and it dominated by Brazil and Mexico. Rest of the world accounts small fraction of global market share due to less adoption. Leadless Pacemakers market players include: Medtronic, Abbott and others. Market is majorly dominated by few players and market is expected to witness new entries during forecast period. Leadless Pacemakers Market Segmentation By Indication Atrial Fibrillation

High Degree Atrioventricular Block

Sinus node dysfunction By End User Hospitals

Catheterization Laboratories By Region North America

Latin America

Europe

Asia Pacific

Rest of the World Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share

• Tier 2 players

• Emerging players which are growing rapidly

• New Entrants FutureWise Key Takeaways

• Growth prospects

• SWOT analysis

• Key trends

• Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global Leadless Pacemakers Market by Indication, by End-User, by Region

• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

• To evaluate and forecast micro-markets and the overall market

• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East

• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

• Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement

• The customization Mobility Care offered are free of charge with purchase of any license of the report

• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com